No IPTi | IPTi | OR | 95% CI | p | |||
---|---|---|---|---|---|---|---|
Molecular Markers | n | Prevalence (95% CI) | n | Prevalence (95% CI) | |||
DHPS 437 | 432 | 19.4% (15.1 - 24.6) | 479 | 21.7% (17.4-26.7) | 1.15 | 0.59- 2.24 | 0.68 |
DHPS 540 | 428 | 0.9% (0.2-3.1) | 474 | 1.0% (0.3-3.1) | 1.13 | 0.16-7.99 | 0.90 |
DHFR 51 | 379 | 56.5% (50.1-62.6) | 402 | 51.0% (44.9-57.1) | 0.80 | 0.52-1.23 | 0.32 |
DHFR 59 | 376 | 55.3% (48.9-61.5) | 402 | 51.0% (44.9-57.1) | 0.84 | 0.50-1.40 | 0.51 |
DHFR 108 | 375 | 56.8% (50.4-63.0) | 392 | 47.7% (41.5-53.9) | 0.69 | 0.47-1.03 | 0.07 |
Triple DHFR mutation (DHFR 51, 59 and 108) | 368 | 44.8% (38.5-51.3) | 384 | 38.5% (32.6-44.8) | 0.77 | 0.50-1.19 | 0.24 |
Quadruple mutation (DHFR 51, 59 and 108 + DHPS 437) | 367 | 11.2% (7.6-16.0) | 379 | 11.6% (8.1-16.4) | 1.04 | 0.51-2.12 | 0.90 |